Tweeter button Delicious button Digg button Stumbleupon button
Cirrhosis | Research And Markets: Cirrhosis – Pipeline Review, H2 2011 Features Companies …

Research and Markets ( ) has announced the addition of Global Markets Direct’s new report ” Cirrhosis – Pipeline Review, H2 2011 ” to their offering.

Global Markets Direct’s, ‘ Cirrhosis – Pipeline Review, H2 2011 ‘, provides an overview of the Cirrhosis therapeutic pipeline. This report provides information on the therapeutic development for Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cirrhosis. ‘ Cirrhosis – Pipeline Review, H2 2011 ‘ is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.


Scope

A snapshot of the global therapeutic scenario for Cirrhosis.

A review of the Cirrhosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Coverage of products based on various stages


Click here to view rest of article from original site

Primary Biliary Cirrhosis Awareness Ribbon Mouse Pad  by Primary Biliary Cirrhosis Awareness Ribbon Mouse Pad  by
yheritagewear
Primary Biliary Cirrhosis Awareness Ribbon Tile Trivet  by Primary Biliary Cirrhosis Awareness Ribbon Tile Trivet  by
yheritagewear



Facebook Twitter Email

Posted on November 26, 2011, 3:44 am By
Categories: cirrhosis Tags:
Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.